Stem cells and regenerative medicine on the Asian horizon: An economic, industry and social perspective

Regenerative Medicine

Volumn 4, Issue 6, 2009, Pages 911-918

  Sipp, Douglas ^a  

^a RIKEN Center for Biosystems Dynamics Research   (Japan)

Author keywords

Asian science; Intellectual property; Regenerative medicine; Stem cell tourism; Stem cells

Indexed keywords

ASIA; BIOMEDICINE; CLINICAL RESEARCH; COMPETITION; EMBRYONIC STEM CELL; FUNDING; GEOGRAPHIC DISTRIBUTION; HEALTH CARE INDUSTRY; HEALTH CARE POLICY; HISTORICAL RESEARCH; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; SOCIAL ASPECT; SOCIAL NETWORK; STEM CELL TRANSPLANTATION; SUPPORT GROUP; TREND STUDY; ECONOMICS; MEDICAL RESEARCH; PHYSIOLOGY; SOCIAL SUPPORT; STEM CELL;

ASIA; BIOMEDICAL RESEARCH; HUMANS; REGENERATIVE MEDICINE; SOCIAL SUPPORT; STEM CELLS;

EID: 75649099041     PISSN: 17460751     EISSN: None     Source Type: Journal    
DOI: 10.2217/rme.09.60     Document Type: Review

References (15)

1. NPG: Asia-Pacifc Networks: Promoting excellence in research. Nature Publishing Group, London, UK 8 (2007).
2. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al.: Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147 (1998).
3. Campbell KH, McWhir J, Ritchie WA, Wilmut I: Sheep cloned by nuclear transfer from a cultured cell line. Nature 380, 64-66 (1996).
4. Wakayama T, Perry AC, Zuccotti M, Johnson KR, Yanagimachi R: Full-term development of mice from enucleated oocytes injected with cumulus cell nuclei. Nature 394, 369-374 (1998).
5. Einhorn B, Veale J, Kripalani M: Asia is stem cell central. In: BusinessWeek. New York City, NY, USA (2005).
6. Cyranoski D: Stem-cell research: crunch time for Korea's cloners. Nature 429, 12-14 (2004).
7. Kennedy D: Editorial retraction. Science 311, 335 (2006).
8. Sipp D: Stem cell research in Asia: a critical view. J. Cell Biochem. 107(5), 853-856 (2009).
9. Normile D: Biotechnology. Singapore frm abandons plans for stem cell therapies. Science 317, 305 (2007).
10. Khang G: Recent activities of regerative medicine in Korea. Tissue Eng. Regen. Med. 3, 371-375 (2006).
11. Bergman K, Graff GD: The global stem cell patent landscape: implications for effcient technology transfer and commercial development. Nat. Biotechnol. 25, 419-424 (2007).
12. Cyranoski D: Stem-cell therapy faces more scrutiny in China. Nature 459, 146-147 (2009).
13. Qiu J: China clamps down on controversial therapies. Lancet 373, 1834-1835 (2009).
14. Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fbroblast cultures by defned factors. Cell 126, 663-676 (2006).
15. Huang J: High potential for medical tourism. Taipei Times 3 August 2009.